BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | A075579 | EPIC PHARMA LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2007-P-0177 · 7 docket documents Lachman Consultant Services, Inc. filed this citizen petition under Section 505(j)(2)(C) of the Federal Food, Drug and Cosmetic Act requesting that the FDA declare Bisoprolol Fumarate and Hydrochlorothiazide Tablets in strengths of 5 mg/12.5 mg, 10 mg/12.5 mg, and 20 mg/12.5 mg suitable for submissi | Other | 2008-05-06 | Partially Denied | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.